GH Research (GHRS) Competitors $9.10 +0.40 (+4.60%) Closing price 04/17/2025 04:00 PM EasternExtended Trading$9.02 -0.08 (-0.93%) As of 04/17/2025 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock GHRS vs. BHC, BHVN, TARS, GMTX, AAPG, BLTE, NAMS, MTSR, ARQT, and RXRXShould you be buying GH Research stock or one of its competitors? The main competitors of GH Research include Bausch Health Companies (BHC), Biohaven (BHVN), Tarsus Pharmaceuticals (TARS), Gemini Therapeutics (GMTX), Ascentage Pharma Group International (AAPG), Belite Bio (BLTE), NewAmsterdam Pharma (NAMS), Metsera (MTSR), Arcutis Biotherapeutics (ARQT), and Recursion Pharmaceuticals (RXRX). These companies are all part of the "pharmaceutical products" industry. GH Research vs. Bausch Health Companies Biohaven Tarsus Pharmaceuticals Gemini Therapeutics Ascentage Pharma Group International Belite Bio NewAmsterdam Pharma Metsera Arcutis Biotherapeutics Recursion Pharmaceuticals GH Research (NASDAQ:GHRS) and Bausch Health Companies (NYSE:BHC) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their dividends, institutional ownership, risk, analyst recommendations, profitability, earnings, valuation, community ranking and media sentiment. Does the media refer more to GHRS or BHC? In the previous week, Bausch Health Companies had 8 more articles in the media than GH Research. MarketBeat recorded 8 mentions for Bausch Health Companies and 0 mentions for GH Research. Bausch Health Companies' average media sentiment score of 0.57 beat GH Research's score of 0.00 indicating that Bausch Health Companies is being referred to more favorably in the news media. Company Overall Sentiment GH Research Neutral Bausch Health Companies Positive Do institutionals and insiders believe in GHRS or BHC? 56.9% of GH Research shares are held by institutional investors. Comparatively, 78.7% of Bausch Health Companies shares are held by institutional investors. 41.6% of GH Research shares are held by insiders. Comparatively, 8.1% of Bausch Health Companies shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Which has higher valuation & earnings, GHRS or BHC? GH Research has higher earnings, but lower revenue than Bausch Health Companies. Bausch Health Companies is trading at a lower price-to-earnings ratio than GH Research, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioGH ResearchN/AN/A-$35.59M-$0.75-12.13Bausch Health Companies$9.63B0.20-$46M-$0.12-42.71 Which has more risk and volatility, GHRS or BHC? GH Research has a beta of 0.84, meaning that its stock price is 16% less volatile than the S&P 500. Comparatively, Bausch Health Companies has a beta of 0.43, meaning that its stock price is 57% less volatile than the S&P 500. Do analysts prefer GHRS or BHC? GH Research presently has a consensus price target of $30.86, suggesting a potential upside of 239.09%. Bausch Health Companies has a consensus price target of $7.17, suggesting a potential upside of 39.84%. Given GH Research's stronger consensus rating and higher possible upside, research analysts plainly believe GH Research is more favorable than Bausch Health Companies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score GH Research 0 Sell rating(s) 0 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 3.00Bausch Health Companies 1 Sell rating(s) 6 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.86 Does the MarketBeat Community favor GHRS or BHC? Bausch Health Companies received 329 more outperform votes than GH Research when rated by MarketBeat users. However, 76.92% of users gave GH Research an outperform vote while only 61.16% of users gave Bausch Health Companies an outperform vote. CompanyUnderperformOutperformGH ResearchOutperform Votes3076.92% Underperform Votes923.08% Bausch Health CompaniesOutperform Votes35961.16% Underperform Votes22838.84% Is GHRS or BHC more profitable? GH Research has a net margin of 0.00% compared to Bausch Health Companies' net margin of -0.48%. GH Research's return on equity of -20.29% beat Bausch Health Companies' return on equity.Company Net Margins Return on Equity Return on Assets GH ResearchN/A -20.29% -19.49% Bausch Health Companies -0.48%-577.82%5.24% SummaryGH Research beats Bausch Health Companies on 10 of the 17 factors compared between the two stocks. Get GH Research News Delivered to You Automatically Sign up to receive the latest news and ratings for GHRS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart GHRS vs. The Competition Export to ExcelMetricGH ResearchPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$473.46M$6.44B$5.29B$7.35BDividend YieldN/A3.23%5.12%4.31%P/E Ratio-11.526.8821.7117.77Price / SalesN/A231.36379.3997.65Price / CashN/A65.6738.2234.64Price / BookN/A5.916.443.98Net Income-$35.59M$142.72M$3.21B$247.44M7 Day Performance1.11%4.33%2.81%1.82%1 Month Performance-14.15%-12.80%-8.67%-6.98%1 Year Performance-18.68%-9.71%11.32%1.49% GH Research Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)GHRSGH Research2.4196 of 5 stars$9.10+4.6%$30.86+239.1%-17.2%$473.46MN/A-11.5210BHCBausch Health Companies4.0906 of 5 stars$5.26-1.4%$7.17+36.4%-40.8%$1.93B$9.63B-43.7919,900Short Interest ↑BHVNBiohaven3.6545 of 5 stars$17.86-3.9%$62.77+251.4%-53.8%$1.82BN/A-1.91239Analyst RevisionTARSTarsus Pharmaceuticals2.8573 of 5 stars$47.49+1.0%$63.67+34.1%+43.1%$1.82B$182.95M-12.4650Positive NewsGMTXGemini TherapeuticsN/A$41.22-9.9%N/A+35.4%$1.79BN/A-41.2230High Trading VolumeAAPGAscentage Pharma Group InternationalN/A$20.40-2.6%N/AN/A$1.78B$980.65M0.00600Positive NewsBLTEBelite Bio2.6293 of 5 stars$55.67-2.2%$96.67+73.6%+74.5%$1.77BN/A-50.1510Short Interest ↓Analyst RevisionNews CoverageNAMSNewAmsterdam Pharma2.6262 of 5 stars$15.86+0.3%$43.33+173.2%-18.5%$1.74B$45.56M-6.104Short Interest ↑High Trading VolumeMTSRMetseraN/A$16.45-2.1%$47.00+185.7%N/A$1.73BN/A0.0081High Trading VolumeARQTArcutis Biotherapeutics3.0647 of 5 stars$14.30-2.9%$18.80+31.5%+26.9%$1.70B$196.54M-7.99150Gap DownRXRXRecursion Pharmaceuticals2.1745 of 5 stars$4.20-0.9%$8.25+96.4%-26.4%$1.69B$58.49M-2.75400Analyst RevisionHigh Trading Volume Related Companies and Tools Related Companies Bausch Health Companies Alternatives Biohaven Alternatives Tarsus Pharmaceuticals Alternatives Gemini Therapeutics Alternatives Ascentage Pharma Group International Alternatives Belite Bio Alternatives NewAmsterdam Pharma Alternatives Metsera Alternatives Arcutis Biotherapeutics Alternatives Recursion Pharmaceuticals Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:GHRS) was last updated on 4/18/2025 by MarketBeat.com Staff From Our PartnersThe Last Time Stocks Looked Like This, They Didn’t Move For 16 YearsThere is nothing the Federal Reserve can do to stop what's coming next for U.S. stocks. As you've seen your...Stansberry Research | SponsoredHow War with China Could Start in 128 DaysThe clock is ticking. Those who aren't prepared could lose everything. I've identified 43 investments we...Behind the Markets | SponsoredMy prediction is coming trueWe've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...InvestorPlace | Sponsored🥾⛏️👷♂️ What I Learned From Numerous Mine Visits...Twenty years ago, I made a decision that changed my life. Instead of sitting behind a desk analyzing mining...Golden Portfolio | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTrump Treasure April 19Thanks to President Trump… A $900 investment across5 specific cryptos… Could gain 12,000% so quickly tha...Paradigm Press | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GH Research PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share GH Research With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy GHRS Stock Free GHRS Stock Alerts